R/Medicine 2026 starts with 2 days of in-depth demos and workshops TOMORROW!
There's still time to register!
Full program here: https://rconsortium.github.io/RMedicine_website/Program.html
R/Medicine 2026 starts with 2 days of in-depth demos and workshops TOMORROW!
There's still time to register!
Full program here: https://rconsortium.github.io/RMedicine_website/Program.html
Full briefing — the morning intelligence for investors and analysts:
https://burns-media.com/biotech/archive/2026-05-04?utm_source=mastodon&utm_medium=social&utm_campaign=biotech_daily
Free. Delivered by 7 AM ET, every weekday.
This note highlights a shift in the evidence base for dementia interventions, underscoring the need for cautious interpretation of treatment benefits and risks. For mental health professionals, the finding that amyloid-clearing therapies may offer little patient-level improvement while elevating brain risk informs discussions about treatment expectations, monitoring, and shared decision-making with clients and families. It also reinforces the importance of considering adverse effects and the overall risk–benefit balance when evaluating pharmacological options within neurodegenerative care.
Article Title: Alzheimer’s drugs may not work and could raise brain risks
Link to Science Daily Mind-Brain News: https://nolinkpreview.com/www.sciencedaily.com/releases/2026/05/260502233915.htm
#alzheimers #amyloid #neurodegeneration #brainhealth #clinicaltrials #treatmentrisks #drugtherapy #neuropsychology #mindbrainnews #shareddecisionmaking
Full weekend edition + daily archive:
https://burns-media.com/biotech/?utm_source=mastodon&utm_medium=social&utm_campaign=biotech_weekly
Subscribe — free, weekday mornings.
This coming week! R/Consortium 2026! May 5-8, 100% virtual
Two days of in-depth, hands-on demos and workshops, then two days of Keynotes, Talks, Lightning Talks and plenty of time built in for your questions - Connect directly with speakers and peers
Don't miss it!
https://rconsortium.github.io/RMedicine_website/Program.html
Clinical trial: A Pilot Study: Dorsolateral Prefrontal Cortex Transcranial Magnetic Stimulation Target Engagement and Safety in Primary Progressive and Relapsing-remitting Multiple Sclerosis
Clinical trial: Internuclear Ophthalmoplegia and Multiple Sclerosis: a Multicenter Retrospective Study
Clinical trial: A Smart Phone Application to Improve Adoption of the 2024 KDIGO CKD Guidelines